University Of Texas Southwestern Medical Center is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
| Location | Dallas, TX, USA |
|---|---|
| Type | Academic Medical Center / Research University |
| Founded | 1943 |
| Affiliation | University of Texas System |
| Website | [utsouthwestern.edu](https://www.utsouthwestern.edu/) |
The University of Texas Southwestern Medical Center (UT Southwestern) is a premier academic medical center located in Dallas, Texas. Established in 1943, UT Southwestern has grown into one of the nation's leading research institutions, with a particular focus on neuroscience and neurodegenerative disease research.
The medical center comprises three degree-granting schools: UT Southwestern Medical School, UT Southwestern Graduate School of Biomedical Sciences, and UT Southwestern School of Health Professions. It is home to the Peter O'Donnell Brain Institute, one of the largest and most comprehensive neuroscience research centers in the world.
The Peter O'Donnell Brain Institute at UT Southwestern brings together over 600 researchers working on:
| Disease Area | Research Focus |
|---|---|
| Alzheimer's Disease | Amyloid therapeutics, tau imaging, biomarkers, clinical trials |
| Parkinson's Disease | LRRK2 biology, alpha-synuclein, DBS outcomes, gait freezing |
| ALS | SOD1, C9orf72, TDP-43, antisense oligonucleotide therapy |
| Frontotemporal Dementia | GRN, MAPT, clinical phenotyping |
| Traumatic Brain Injury | Chronic traumatic encephalopathy, biomarkers |
UT Southwestern collaborates with:
The study of University Of Texas Southwestern Medical Center has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Diamond M, et al. (2013). "The prion concept and tauopathies." Nature Reviews Neuroscience. PMID:24166279.
Hart RG, et al. (2019). "LRRK2 mutations and Parkinson's disease." Movement Disorders. PMID:30663012.
Beach TG, et al. (2017). "Alzheimer's disease neuropathology in the brains of participants in the Texas Alzheimer's Research and Care Consortium." Journal of Alzheimer's Disease. PMID:28871452.